- info@ayurzenpharma.com
- +91-9000847100
Ayurzen Pharma supplies high-purity active pharmaceutical ingredients across major therapeutic categories including antibiotics and anti-infectives, cardiovascular and metabolic agents, CNS drugs, antidiabetics, gastrointestinal compounds, and NSAIDs. Sourcing is from WHO-GMP and ISO-accredited facilities with validated processes, full CoA/COO support, and global export documentation readiness for regulated and semi-regulated markets.
| SI.No | Product Name | CAS Number | Type | Final Application |
| 1 | Montelukast sodium IP & USP | 151767-02-1 | API | Anti-asthma |
| 2 | Phenylephrine Hydrochloride IP & USP | 61-76-7 | API | Decongestant |
| 3 | Bilastine ( Stability studies in progress ) | 202189-78-4 | API | Anti-histamine |
| 4 | Lacosamide EP & USP . | 175481-36-4 | API | Anti-epileptic |
| 5 | Latanoprost USP | 130209-82-4 | API | Glaucoma & Ocular Hypertension |
| 6 | Bimatoprost USP | 155206-00-1 | API | Glaucoma |
| 7 | Cabergoline USP . | 81409-90-7 | API | Parkinson’s Disease & Prolactin Inhibitor |
| 8 | lopamidol EP & USP | 60166-93-0 | API | lodinated contrast agent |
| 9 | Empagliflozin | 864070-44-0 | API | Lower blood sugar ( type 2 diabetes ) |
| 10 | Elobixibat Hydrate | 1633824-78-8 | API | Anti-constipation |
| 11 | Granisetron Hydrochloride | 107007-99-8 | API | Treatment for Vomiting and nausea at the time of chemotherapy . |
| 12 | Ketoprofen USP & EP | 22071-15-4 | API | anti-inflammatory |
| 13 | Dex ketoprofen trometamol | 156604-79-4 | API | anti-inflammatory and antipyretic |
| 14 | 3-(1-Cyanoethyl ) benzoic acid | 5537-71-3 | API | Ketoprofen |
| 15 | Levocetirizine Di-hydrochloride . IP , USP & EP . | 130018-77-8 | API | Antihistamine |
| 16 | Mirogabalin besylate ( under development ) | 1138245-21-2 | API | Diabetic PNP & Post-herpetic euralgia |
| 17 | Etoricoxib ( under development ) | 202409-33-4 | API | Anti inflammatory |
| 18 | Betahistine Hydrochloride ( under development ) | 5579-84-0 | API | Treatment for Vertigo |
Any references to Blockchain or AI reflect ongoing research/pilot work and are not live production capabilities at this time.
